BioMarin Pharma (BMRN) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500, Dow futures muted after big bank earnings, chip slide weighs
- Oil eases as traders monitor Russian diesel deal, Saudi attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Sysco calls on Teamsters to end LA strike after economic deal reached
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
BioMarin Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Updates
February 23, 2022 4:03 PM ESTSAN RAFAEL, Calif., Feb. 23, 2022 /PRNewswire/ --
Financial Highlights (in millions of U.S. dollars, except per share data, unaudited)Â Â Â Â
Three Months Ended December 31,
Twelve Months Ended December 31,
2021
2020
% Change
... More


